NGFR and melanoma: In their pioneering study, the team of T. Tüting demonstrated in murine models that melanoma tumor cells resisting immunotherapy, based on CD8+ T lymphocytes adoptive cell transfer (ACT), undergo a dedifferentiation process, coordinating the loss of melanoma differentiation markers and the gain of the neural crest marker NGFR (25).